TP53 and acute myeloid leukemia: To evaluate the similarity between mouse and human AML, we performed cellular indexing of transcriptome and epitope sequencing (CITE-Seq) with 12 patients with TP53/TET2-mutant AML, 6 patients with TP53-mutant AML, 6 patients with TET2-mutant AML, and 6 patients with WT AML and projected mouse scRNA-Seq data onto human AML CITE-Seq data (Supplemental Figure 3, C and D).